SecBot SecBot
SC 13G/A ·Filed Nov 17, 2026

YARW

Yarrow Bioscience, Inc.
NEUTRAL
Impact 3/10
Processed1h 37m ago SEC0000935836-26-000626
Passive stake amendment

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000935836-26-000626
Document: 0000935836-26-000626-index-headers.html0000935836-26-000626
Document: 0000935836-26-000626-index.html0000935836-26-000626
Document: 0000935836-26-000626.txt0000935836-26-000626

Track record

13 reports on YARW

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 17, 2026today SC 13G/A Neutral 3/10 Viewing Entry $13.93 Now $14.35 +3.02% settles Dec 16
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $14.20 Now $14.35 +1.06% settles Dec 16
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.35 +3.02% settles Dec 16
  4. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.35 +3.02% settles Dec 16
  5. Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $15.44 Now $14.35 −7.06% settles Dec 15
  6. Nov 16, 20261d ago SC 13G Neutral 3/10 Entry $18.20 Now $14.35 −21.15% settles Dec 15
  7. Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $18.03 Now $14.35 −20.41% settles Dec 15
  8. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $17.35 Now $14.35 −17.29% settles Dec 15
  9. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $18.03 Now $14.35 −20.41% settles Dec 15
  10. Nov 12, 20265d ago 8-K Neutral 4/10 Entry $19.63 Now $14.35 −26.90% settles Dec 11
Showing 10 of 13

US Market Status

Market Open · Closes in 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 17, 2026

Fresh YARW Intelligence

Analysis is for subscribers only.

Subscribe for Full Access